BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4738064)

  • 1. The effects of triglyceride absorption upon glucagon, insulin, and gut glucagon-like immunoreactivity.
    Böttger I; Dobbs R; Faloona GR; Unger RH
    J Clin Invest; 1973 Oct; 52(10):2532-41. PubMed ID: 4738064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
    Ohneda A; Parada E; Eisentraut AM; Unger RH
    J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisomatostatin serum increases levels of hormones from the pituitary and gut, but not from the pancreas.
    Schusdziarra V; Rouiller D; Arimura A; Unger RH
    Endocrinology; 1978 Nov; 103(5):1956-9. PubMed ID: 748027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenously administered glucose on glucagon and insulin secretion during fat absorption.
    Dobbs R; Faloona GR; Unger RH
    Metabolism; 1975 Jan; 24(1):69-75. PubMed ID: 1110626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
    Böttger I; Faloona GR; Unger RH
    J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal metabolism of gut glucagon-like immunoreactivity.
    Rovira A; López-Novoa JM; Zubiaur M; Matesanz R; Ghiglione M; Pascual JM; Valverde I
    Endocrinology; 1982 Jun; 110(6):2030-6. PubMed ID: 6896180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
    Valverde I; Ghiglione M; Matesanz R; Casado S
    Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.
    Sakurai H; Dobbs RE; Unger RH
    Diabetologia; 1975 Oct; 11(5):427-30. PubMed ID: 1181667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric A-cell function in normal dogs.
    Muñoz-Barragan L; Blazquez E; Patton GS; Dobbs RE; Unger RH
    Am J Physiol; 1976 Oct; 231(4):1057-61. PubMed ID: 984193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of secretin upon pancreatic alpha cell function.
    Santeusanio F; Faloona GR; Unger RH
    J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
    Meister R; Berger I; Schwille PO; Gebhardt C
    Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.
    van Citters GW; Kabir M; Kim SP; Mittelman SD; Dea MK; Brubaker PL; Bergman RN
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5191-8. PubMed ID: 12414891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric A-cell function in insulin-deprived depancreatized dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Orci L; Dobbs RE; Unger RH
    Endocrinology; 1976 Nov; 99(5):1182-8. PubMed ID: 991814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.